Hematology NewsOlder age predicts mortality after alloHCT in NHL, but not relapseOctober 24, 2018Aggressive LymphomasCellular TherapyLymphoma & Plasma Cell DisordersFollicular LymphomaB Cell Lymphoma
Hematology NewsEntospletinib falls short in relapsed/refractory DLBCLOctober 11, 2018Aggressive LymphomasLymphoma & Plasma Cell DisordersFollicular LymphomaB Cell Lymphoma
Hematology TimesInhibitor receives orphan designation for PTCLOctober 11, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaFollicular Lymphoma
Hematology NewsFrontline rituximab shows long-term success in indolent lymphomaOctober 5, 2018Indolent LymphomaLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology NewsFDA lifts partial hold on tazemetostat trialsSeptember 30, 2018T Cell LymphomasLymphoma & Plasma Cell DisordersAggressive LymphomasFollicular LymphomaB Cell LymphomaSarcoma & GIST
Hematology NewsFDA approves new drug for CLL/SLL and follicular lymphomaSeptember 25, 2018CLLIndolent LymphomaLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology TimesRisks of watchful waiting in follicular lymphomaSeptember 19, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology NewsBe wary of watchful waiting in follicular lymphomaSeptember 16, 2018Indolent LymphomaLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology NewsNovartis nabs first CAR T approval in CanadaSeptember 7, 2018ALLAggressive LymphomasImmunotherapyFollicular LymphomaB Cell Lymphoma
Hematology TimesFirst CAR T-cell therapy approved in CanadaSeptember 7, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsPharmacyALLAggressive LymphomasFollicular Lymphoma
Hematology TimesRegimens produce similar results in FLSeptember 7, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology NewsRituximab/lenalidomide similar to rituximab/chemotherapy for follicular lymphomaSeptember 6, 2018Indolent LymphomaLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology NewsNew BTK inhibitor under review in ChinaAugust 29, 2018Mantle Cell LymphomaAggressive LymphomasFollicular LymphomaB Cell Lymphoma
Hematology TimesEC approves CAR T-cell therapy for DLBCL, PMBCLAugust 28, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasFollicular LymphomaB Cell Lymphoma
The Journal of Community and Supportive OncologyFirst CAR T-cell therapy approvals bolster booming immunotherapy marketAugust 15, 2018Lymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, TransplantationFollicular LymphomaB Cell Lymphoma
